Radiofrequency Ablation For Recurrent Parathyroid Carcinoma — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Radiofrequency Ablation For Recurrent Parathyroid Carcinoma — Stella

Recruiting

Back to Recurrent Parathyroid Carcinoma trials

Not a traditional drug trial — this study doesn't follow the standard phase structure.

Trial locations(1 site)

United States

UT MD Anderson, Houston, Texas

Key details

Sponsor

M.D. Anderson Cancer Center

Enrollment target

~20 participants

Started

April 2026

Primary completion

April 2029

Age range

18 Years and older

Last updated April 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov